CD8A and cancer: Although PD-1, CTLA-4, LAG-3, and TIM-3 are equally important in CD8+ T cells, this may highlight the synergistic effect of Ogr1 and existing immunosuppressive checkpoint inhibitors in the treatment of advanced cancers.